COVID-19 and fatigue: Where do we go from here? Response to Ortelli et al.

被引：0
作者：
Conti, Isabella [1 ]
Cross, Benjamin [2 ]
Rooney, Alasdair G. [3 ]
Nicholson, Timothy R. [4 ]
机构：
[1] Queens Univ Belfast, Sch Med, Belfast, Antrim, North Ireland
[2] East Lancashire Hosp NHS Trust, Burnley, Lancs, England
[3] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland
[4] Inst Psychiat, Sect Cognit Neuropsychiat, London, England
来源：
JOURNAL OF THE NEUROLOGICAL SCIENCES | 2021年 / 426卷
关键词：
COVID-19; Neuropsychiatry; Neurophysiology;
D O I：
10.1016/j.jns.2021.117470
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Strengthening regulatory systems for medicines in a changed world: where do we go from here?
    O'Brien, Julie
    Lumsden, Rebecca
    Macdonald, Judith
    BMJ GLOBAL HEALTH, 2021, 6 (01):
  • [42] Rebound and steep increase of international travel after the COVID-19 pandemic: where are we going from here?
    Anagnostopoulos, Alexia
    Fehr, Jan
    JOURNAL OF TRAVEL MEDICINE, 2023, 31 (01)
  • [43] Immunosuppression in kidney transplant recipients with COVID-19 infection - where do we stand and where are we heading?
    Daoud, Ahmed
    Alqassieh, Ahmad
    Alkhader, Duaa
    Posadas Salas, Maria Aurora
    Rao, Vinaya
    Fulop, Tibor
    Soliman, Karim M.
    RENAL FAILURE, 2021, 43 (01) : 273 - 280
  • [44] The impact of the coronavirus crisis on European societies. What have we learnt and where do we go from here? - Introduction to the COVID volume
    Grasso, Maria
    Klicperova-Baker, Martina
    Koos, Sebastian
    Kosyakova, Yuliya
    Petrillo, Antonello
    Vlase, Ionela
    EUROPEAN SOCIETIES, 2021, 23 : S2 - S32
  • [45] Therapeutics for COVID-19: from computation to practices-where we are, where we are heading to
    Ojha, Probir Kumar
    Kar, Supratik
    Krishna, Jillella Gopala
    Roy, Kunal
    Leszczynski, Jerzy
    MOLECULAR DIVERSITY, 2021, 25 (01) : 625 - 659
  • [46] Overview of Antiviral Drug Therapy for COVID-19: Where Do We Stand?
    Esposito, Renata
    Mirra, Davida
    Sportiello, Liberata
    Spaziano, Giuseppe
    D'Agostino, Bruno
    BIOMEDICINES, 2022, 10 (11)
  • [47] Genetic Predisposition and Inflammatory Inhibitors in COVID-19: Where Do We Stand?
    Sagris, Marios
    Theofilis, Panagiotis
    Antonopoulos, Alexios S.
    Oikonomou, Evangelos
    Tsioufis, Kostas
    Tousoulis, Dimitris
    BIOMEDICINES, 2022, 10 (02)
  • [48] Response to Smith et al.: Telehealth for global emergencies: Implications for coronavirus disease 2019 (COVID-19)
    Scott, Richard E.
    Mars, Maurice
    JOURNAL OF TELEMEDICINE AND TELECARE, 2020, 26 (06) : 378 - 380
  • [49] Response to COVID-19 Pandemic: Where Do Public Libraries Stand?
    Alajmi, Bibi M.
    Albudaiwi, Dalal
    PUBLIC LIBRARY QUARTERLY, 2021, 40 (06) : 540 - 556
  • [50] Letter in response to the article: Vitamin D concentrations and COVID-19 infection in UK biobank (Hastie et al.)
    Grant, W. B.
    McDonnell, S. L.
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2020, 14 (05) : 893 - 894
12345